Viatris Stock Performance
| VTRS Stock | USD 8.88 0.39 4.21% |
On a scale of 0 to 100, Viatris holds a performance score of 11. The entity has a beta of 1.19, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Viatris will likely underperform. Please check Viatris' downside variance, and the relationship between the total risk alpha and daily balance of power , to make a quick decision on whether Viatris' existing price patterns will revert.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Viatris are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Viatris unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (4.21) | Five Day Return (2.09) | Year To Date Return (28.50) | Ten Year Return (86.74) | All Time Return 17.7 K |
Forward Dividend Yield 0.0538 | Payout Ratio | Last Split Factor 3:2 | Forward Dividend Rate 0.48 | Dividend Date 2025-06-16 |
1 | Viatris Inc Faces Securities Fraud Class Action Lawsuit VTRS stock news | 05/27/2025 |
2 | Viatris Inc. Securities Fraud Class Action Lawsuit Pending Contact Levi Korsinsky Before ... | 05/30/2025 |
3 | Viatris Announces Positive Top-Line Results from Phase 3 LYNX-2 Trial of MR-142 in ... | 06/02/2025 |
4 | 3 Generic Drug Stocks to Watch Amid Pricing Pressure Tariff Threats | 06/09/2025 |
5 | Viatris to Report Second Quarter 2025 Financial Results on August 7, 2025 VTRS Stock News | 06/12/2025 |
| Viatris dividend paid on 16th of June 2025 | 06/16/2025 |
6 | 3 Reasons to Avoid VTRS and 1 Stock to Buy Instead | 06/17/2025 |
7 | Viatris The Problem With The Business Model - Seeking Alpha | 06/25/2025 |
8 | Viatris Inc Announces Positive Results from Phase 3 VEGA-3 Trial for Presbyopia ... | 06/26/2025 |
9 | Viatris Inc. Stock Analysis Exploring A Potential 26 percent Upside Amidst Volatility - DirectorsTalk Interviews | 06/30/2025 |
10 | Goldman Sachs Reiterates a Hold Rating on Viatris With a 10 PT | 07/11/2025 |
11 | Viatris Gains China Approval for COPD Drug Yupelri, Triggers 7.5M Payment to Theravance BioPharma | 07/15/2025 |
12 | Viatris Announces Positive Top-line Results from VEGA-3 | 07/17/2025 |
| Begin Period Cash Flow | 993.6 M | |
| Total Cashflows From Investing Activities | 1.8 B |
Viatris Relative Risk vs. Return Landscape
If you would invest 746.00 in Viatris on April 21, 2025 and sell it today you would earn a total of 142.00 from holding Viatris or generate 19.03% return on investment over 90 days. Viatris is currently generating 0.2968% in daily expected returns and assumes 2.0104% risk (volatility on return distribution) over the 90 days horizon. In different words, 18% of stocks are less volatile than Viatris, and 95% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Viatris Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Viatris' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Viatris, and traders can use it to determine the average amount a Viatris' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1476
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | VTRS | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.01 actual daily | 18 82% of assets are more volatile |
Expected Return
| 0.3 actual daily | 6 94% of assets have higher returns |
Risk-Adjusted Return
| 0.15 actual daily | 11 89% of assets perform better |
Based on monthly moving average Viatris is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Viatris by adding it to a well-diversified portfolio.
Viatris Fundamentals Growth
Viatris Stock prices reflect investors' perceptions of the future prospects and financial health of Viatris, and Viatris fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Viatris Stock performance.
| Return On Equity | -0.21 | ||||
| Return On Asset | 0.0223 | ||||
| Profit Margin | (0.26) % | ||||
| Operating Margin | 0.06 % | ||||
| Current Valuation | 23.94 B | ||||
| Shares Outstanding | 1.17 B | ||||
| Price To Earning | 15.16 X | ||||
| Price To Book | 0.67 X | ||||
| Price To Sales | 0.73 X | ||||
| Revenue | 14.74 B | ||||
| Gross Profit | 5.83 B | ||||
| EBITDA | 2.82 B | ||||
| Net Income | (634.2 M) | ||||
| Cash And Equivalents | 741.9 M | ||||
| Cash Per Share | 0.61 X | ||||
| Total Debt | 14.31 B | ||||
| Debt To Equity | 1.07 % | ||||
| Current Ratio | 1.46 X | ||||
| Book Value Per Share | 13.20 X | ||||
| Cash Flow From Operations | 2.3 B | ||||
| Earnings Per Share | (3.18) X | ||||
| Market Capitalization | 10.42 B | ||||
| Total Asset | 41.5 B | ||||
| Retained Earnings | 3.42 B | ||||
| Working Capital | 3.74 B | ||||
About Viatris Performance
Assessing Viatris' fundamental ratios provides investors with valuable insights into Viatris' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Viatris is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 154.32 | 169.21 | |
| Return On Tangible Assets | (0.04) | (0.04) | |
| Return On Assets | (0.02) | (0.01) | |
| Return On Equity | (0.03) | (0.03) |
Things to note about Viatris performance evaluation
Checking the ongoing alerts about Viatris for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Viatris help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Viatris has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 14.74 B. Net Loss for the year was (634.2 M) with profit before overhead, payroll, taxes, and interest of 5.83 B. | |
| Over 85.0% of the company outstanding shares are owned by institutional investors | |
| On 16th of June 2025 Viatris paid $ 0.12 per share dividend to its current shareholders | |
| Latest headline from finance.yahoo.com: Viatris Announces Positive Top-line Results from VEGA-3 |
- Analyzing Viatris' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Viatris' stock is overvalued or undervalued compared to its peers.
- Examining Viatris' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Viatris' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Viatris' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Viatris' stock. These opinions can provide insight into Viatris' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Viatris Stock Analysis
When running Viatris' price analysis, check to measure Viatris' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Viatris is operating at the current time. Most of Viatris' value examination focuses on studying past and present price action to predict the probability of Viatris' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Viatris' price. Additionally, you may evaluate how the addition of Viatris to your portfolios can decrease your overall portfolio volatility.